Connection
Jordan Karlitz to Middle Aged
This is a "connection" page, showing publications Jordan Karlitz has written about Middle Aged.
|
|
Connection Strength |
|
 |
|
 |
|
0.348 |
|
|
|
-
Montminy EM, Zhou M, Maniscalco L, Heda R, Kim MK, Patel SG, Wu XC, Itzkowitz SH, Karlitz JJ. Shifts in the Proportion of Distant Stage Early-Onset Colorectal Adenocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2022 02; 31(2):334-341.
Score: 0.043
-
Montminy EM, Zhou M, Maniscalco L, Penrose H, Yen T, Patel SG, Wu XC, Karlitz JJ. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017. JAMA Netw Open. 2021 11 01; 4(11):e2130433.
Score: 0.043
-
Karlitz JJ, Phillips A, Sorrells KS, Rao S. Genetic Analysis of Archived Tumor Specimens for Hereditary Colorectal Cancer Syndromes in the Cajuns of Louisiana, a US Founder Population. Clin Transl Gastroenterol. 2021 09 21; 12(9):e00392.
Score: 0.042
-
Montminy EM, Zhou M, Maniscalco L, Abualkhair W, Kim MK, Siegel RL, Wu XC, Itzkowitz SH, Karlitz JJ. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States. Ann Intern Med. 2021 02; 174(2):157-166.
Score: 0.040
-
Abualkhair WH, Zhou M, Ochoa CO, Lacayo L, Murphy C, Wu XC, Karlitz JJ. Geographic and intra-racial disparities in early-onset colorectal cancer in the SEER 18 registries of the United States. Cancer Med. 2020 12; 9(23):9150-9159.
Score: 0.040
-
Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ. Trends in Incidence of Early-Onset Colorectal Cancer in the United States Among Those Approaching Screening Age. JAMA Netw Open. 2020 01 03; 3(1):e1920407.
Score: 0.037
-
Karlitz JJ, Hsieh MC, Liu Y, Blanton C, Schmidt B, Jessup JM, Wu XC, Chen VW. Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients =50: Prevalence, Testing Determinants, and Result Availability Prior to Colon Surgery. Am J Gastroenterol. 2015 Jul; 110(7):948-55.
Score: 0.027
-
Greene M, Pew T, Ozbay AB, Rinc?n L?pez JV, Brooks D, Karlitz J, Duarte M. Impact of Spanish Language Outreach on Multi-Target Stool DNA Test Adherence in a Federally Qualified Health Center in the United States. Cancer Control. 2025 Jan-Dec; 32:10732748251343334.
Score: 0.014
-
Yen T, Scolaro J, Montminy E, Karlitz JJ, Wani S, Patel SG. Spectrum of Advanced Colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50. Clin Gastroenterol Hepatol. 2023 03; 21(3):827-829.e3.
Score: 0.011
-
Fendrick AM, Fisher DA, Saoud L, Ozbay AB, Karlitz JJ, Limburg PJ. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes. Cancer Prev Res (Phila). 2021 09; 14(9):845-850.
Score: 0.010
-
Dwyer AJ, Murphy CC, Boland CR, Garcia R, Hampel H, Limburg P, Lowery J, Zauber AG, Waring S, Worrall S, Perea J, Siegel R, Lee J, Molmenti C, Sears CL, Buckhaults P, Hayes R, Hussan H, de Miranda N, Palles C, Diaz L, Song M, Cercek A, Lieu CH, Patel SG, Karlitz JJ, Cao Y, Demb J, Blatchford P, Risendal B, Staples ES, Wali A, Daschner P, Loomans-Kropp H, Flores R, Levell CL, Wehling K, Martin J, Pesmen C, Kuchar V, Soisson R, Davis A, Ahnen D. A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer. Gastroenterology. 2019 08; 157(2):280-288.
Score: 0.009
-
Montminy EM, Karlitz JJ, Landreneau SW. Progress of colorectal cancer screening in United States: Past achievements and future challenges. Prev Med. 2019 03; 120:78-84.
Score: 0.009
-
Charlton ME, Kahl AR, Greenbaum AA, Karlitz JJ, Lin C, Lynch CF, Chen VW. KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010-2013. J Natl Compr Canc Netw. 2017 12; 15(12):1484-1493.
Score: 0.008
-
Charlton ME, Karlitz JJ, Schlichting JA, Chen VW, Lynch CF. Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study. Am J Clin Oncol. 2017 Oct; 40(5):498-506.
Score: 0.008
-
Feuerstadt P, Bunim AL, Garcia H, Karlitz JJ, Massoumi H, Thosani AJ, Pellecchia A, Wolkoff AW, Gaglio PJ, Reinus JF. Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients. Hepatology. 2010 Apr; 51(4):1137-43.
Score: 0.005
-
Keller CE, Gamboa ET, Hays AP, Karlitz J, Lowe G, Green PH, Bhagat G. Fatal CNS vasculopathy in a patient with refractory celiac disease and lymph node cavitation. Virchows Arch. 2006 Feb; 448(2):209-13.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|